Advertisement

Topics

biOasis Technologies, Inc. Company Profile

21:48 EDT 18th June 2019 | BioPortfolio

biOasis Technologies Inc. is a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The delivery of therapeutics across the BBB represents the single greatest challenge in treating neurological disorders. The company is developing and commercializing the xB3 platform, biOasis’ proprietary blood-brain barrier delivery technology, to address unmet medical needs in the treatment of central nervous system diseases and disorders. The company maintains headquarters in Vancouver, Canada with offices in Connecticut, United States. BiOasis trades on the OTCQB under the symbol “BIOAF” and on the TSX Venture Exchange under the symbol “BTI.” For more information about the company please visit www.bioasis.ca.


News Articles [314 Associated News Articles listed on BioPortfolio]

Bioasis reports positive results from peripheral whole─body PET/CT scan study in non─human primates with xB3─001

Bioasis Technologies Inc, a pre─clinical, research─stage biopharmaceutical company, has announced data using the company's lead investigational candidate xB3─001 in an advanced positron emission...

Bioasis Technologies to meet with FDA June 2019 on it xB3 platform technology

Bioasis Technologies Inc. (OTCQB:BIOAF) (TSX.V:BTI) Director, President & CEO Dr. Mark Day sat down with Proactive Investors at the BIO CEO & Investor Conference in New York. The Connectic...

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2018

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a biopharmaceutical company developing its xB3 TM proprietary platform technology for the delivery of therapeutics ...

Bioasis Technologies Inc. Announces Warrant Extension

BIOASIS TECHNOLOGIES INC. (“Bioasis” or the “Company”) (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its propri...

Bioasis to Present at Investor & Industry Conferences in January 2019

Bioasis Technologies Inc. (TSX.V:BTI)(OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing ...

Bioasis Appoints Mario Saltarelli as Non-Executive Director of the Board of Directors

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), ), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technol...

Bioasis Appoints Dr. Deborah Rathjen as President & Chief Executive Officer

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for ...

Bioasis Announces Private Placement

This News Release is Not for Distribution to U.S. Newswire Services or Dissemination in the United States BIOASIS TECHNOLOGIES INC. (“Bioasis” or the “Company”)...

PubMed Articles [361 Associated PubMed Articles listed on BioPortfolio]

Using structural diversity to measure the complexity of technologies.

The paper introduces structural diversity as a new approach to quantify the complexity of technologies. By modeling technologies as combinatorial networks, a measure of technological complexity is der...

Information and communication technologies for weight loss.

The potential of information and communication technologies has quickly been identified for health and in particular to promote weight loss. Several types of technologies exist with varying degrees of...

The Modern Medical Technologies in Orphan Diseases Prevention.

The article covers issues of organization of orphan diseases prevention using modern technologies. The role of preconception training, medical genetic counseling, auxiliary reproductive technologies, ...

Special Issue: Drug Delivery Systems and Technologies Part I.

Comparing the effects of thermal and non-thermal technologies on pomegranate juice quality: A review.

The consumption of pomegranate juice (PJ) has increased substantially since scientific literature reported its therapeutic benefits that are attributable to antioxidant, antimicrobial, anti-carcinogen...

Clinical Trials [518 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1300 Associated Companies listed on BioPortfolio]

biOasis Technologies, Inc.

biOasis Technologies Inc. is a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The delivery of t...

biOasis Technologies Inc.

biOasis Technologies Inc. is a biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The delivery of t...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

SensiQ Technologies, Inc.

SensiQ Technologies, Inc. develops and manufactures innovative tools for the advancement of life sciences research. SensiQ Technologies offers a suite of instruments and platforms...

More Information about "biOasis Technologies, Inc." on BioPortfolio

We have published hundreds of biOasis Technologies, Inc. news stories on BioPortfolio along with dozens of biOasis Technologies, Inc. Clinical Trials and PubMed Articles about biOasis Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of biOasis Technologies, Inc. Companies in our database. You can also find out about relevant biOasis Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Delivery
<!--LGfEGNT2Lhm-->Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals.  <!--LGfEGNT2Lhm-->Drug delivery technologies are <!--LGfEGNT2Lhm-->patent pr...


Corporate Database Quicklinks



Searches Linking to this Company Record